CAVIFAST 2 - Cavitation

The CAVIFAST 2 is a low frequency ultrasound device with a cavitational effect. This DERMEO device reduces the volume of the treated area by lipolysis (fat cell volume reduction) and lipoclasia (rupture of the membrane of the adipocytes) in fat cells, which leads to a loss in centimeters and an improvement of the quality of the skin. 

The CAVIFAST2 device is based on low frequency ultrasounds (about 38kHz +/- 2kHz). 

The CAVIFAST2 device, designed for professionals in the medical and aesthetic industry, is a latest generation cavitation device with an efficiency and safety that have been proven by dermatologists, and by a clinical study on the remains of abdominoplasty which have been kept alive, at the hospital la PITIE SALPETRIERE in Paris. 

Quick, effective, and non-invasive treatments. The results are visible and measurable from the first session



Low frequency ultrasound technology 

The CAVIFAST 2 device emits low frequency ultrasounds onto the skin's surface, which penetrate up to 4 cm. This depth corresponds to an action in the innermost layer of the skin: the hypodermis layer, containing the fat reserves in the body. Ultrasounds are emitted by means of handheld transducers, also known as hand pieces. They convert electrical energy into ultrasonic mechanical energy.

A transducer is composed of two pieces of ceramic, adjusted so they do not create overheating. Upon activation of the device, the two pieces of ceramic vibrate simultaneously but each at a different frequency, creating ultrasounds.

  Why It Works

Cavitation is the emission of ultrasounds within a liquid environment. When the liquid is submitted to a high intensity pressure ultrasound wave, micro-cavity bubbles are formed and their volume increases until they implode.

The generated thermal energy during this phenomenon and the compressing and decompressing waves, are responsible for the implosion of the micro-cavities.

The cavitation principle allows the treatment of excess localized fat and reduces the built-up layers in order to lose centimeters from the treated zone. Low frequency ultrasounds generated by the transducers use the water located in our cells to form bubbles.

These bubbles increase in volume until they implode, thus weakening the membrane of the adipocytes and releasing the triglycerides.

Cavitation provides a loss in centimetres of the treated area with visible results from the first session. It is important to stay hydrated before, during and after the session to facilitate the release of fat.



Cavitation can treat fatty areas such as :

  • Arms
  • The abdomen
  • The hips (love handles)
  • Top of the thighs (saddle bags)
  • The buttocks
  • Thighs

Length of treatment: 10 minutes per zone of 10 cm x10 cm.
For optimal treatment, 5 to 6 sessions may be necessary.

Proven results

The results of the study showed for all donors a nearly doubled increase of glycerol released compared to the “normal” skin after only 10 minutes treatment with CAVIFAST2.

According to our clinical study conducted by a medical specialist and a clinical researcher on volunteer patients, all subjects who volunteered for slimming treatments showed excellent results that were visible from the first session.

  Clinical Studies

Scientific studies of the cavitation effect 

A clinical study was conducted by the GREDECO laboratory to demonstrate the quality and efficiency of the DERMEO® device. This study was carried out on fragments of human skin, by researchers of the GREDECO laboratory in the Pitié-Salpêtrière hospital in Paris. 

Histological cuts of these skin fragments showed a non-invasive lipoclasia and no alteration of the dermo-hypodermic junction. 

Compliance with the essential structures of the skin such as epidermis, dermis and blood vessels demonstrates the perfect safety of treatments with the CAVIFAST2. 

Glycerol release 

For all donors, the results of the study showed an increased level of glycerol which was nearly twice the level of the glycerol release of the untreated control skin, and this, after only 10 minutes of treatment with the CAVIFAST 2. 

A clinical study was conducted by a clinical research associate, and a Doctor of Medicine with the DERMEO CAVIFAST 2 device. Performed on volunteer patients, visible and very satisfactory results were visible from the first session. Each treated patient was aged 20-67 years, had a very good tolerance to ultrasonic cavitation technology, and demontrated a measurable circumference reduction from the first treatment.

  Product Demonstration Video


* This page is for information purposes only. The product displayed on this page is not currently approved by Health Canada.
This device has not been licensed for sale in Canada in accordance with Canadian Law.